Regeneron Pharmaceuticals Note Agreements
2 Contracts & Agreements
- REGENERON PHARMACEUTICALS, INC. 1.875% Convertible Senior Notes due 2016 (Filed With SEC on October 24, 2011)
- REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 PURCHASE AGREEMENT (Filed With SEC on October 24, 2011)
